Book contents
- Club Drugs and Novel Psychoactive Substances
- Club Drugs and Novel Psychoactive Substances
- Copyright page
- Contents
- Acknowledgements
- Part I Introduction
- Chapter 1 Introduction
- Chapter 2 What Are Club Drugs and NPS and Why Are They Important?
- Chapter 3 A Brief History of NPS Production and Distribution
- Chapter 4 Classification Framework for Club Drugs and NPS
- Chapter 5 The Clinical Challenge of Club Drugs and NPS
- Part II Stimulant Drugs
- Part III Depressant Drugs
- Part IV Synthetic Cannabinoid Receptor Agonists
- Part V Hallucinogens
- References
- Index
Chapter 4 - Classification Framework for Club Drugs and NPS
from Part I - Introduction
Published online by Cambridge University Press: 21 September 2020
- Club Drugs and Novel Psychoactive Substances
- Club Drugs and Novel Psychoactive Substances
- Copyright page
- Contents
- Acknowledgements
- Part I Introduction
- Chapter 1 Introduction
- Chapter 2 What Are Club Drugs and NPS and Why Are They Important?
- Chapter 3 A Brief History of NPS Production and Distribution
- Chapter 4 Classification Framework for Club Drugs and NPS
- Chapter 5 The Clinical Challenge of Club Drugs and NPS
- Part II Stimulant Drugs
- Part III Depressant Drugs
- Part IV Synthetic Cannabinoid Receptor Agonists
- Part V Hallucinogens
- References
- Index
Summary
Hundreds of new substances have emerged in the last decade. For most clinicians, it is not possible to develop expertise in each and every existing NPS, or those likely to emerge in the future.
- Type
- Chapter
- Information
- Club Drugs and Novel Psychoactive SubstancesThe Clinician's Handbook, pp. 11 - 12Publisher: Cambridge University PressPrint publication year: 2020